It will? You can predict the stock market?! :-)
If the Phase 2A Part A results are good, I suspect the company's market cap will rival and perhaps even pass AXON fully diluted. That would mean mid $20's (we have to include the shares represented by warrants and options). It may hold, it may not. Stocks are volatile, so it will almost certainly "overshoot" and retrace a bit, though at price and when we cannot know; we can't read the minds of thousands of market participants and their trading, investing, tax, and portfolio planning goals. Nor can we predict the timing of any partnership announcement, analyst targets, and bearish articles.
For longs, buy the amount of stock you are comfortable with, keep fingers crossed on Nov 7, and if it's good news continue to hold and ignore the volatility.